Related Experiment Videos
Stimulation of the nervous system for the management of seizures: current and future developments
Jerome V Murphy1, Arunangelo Patil
1Pediatric Epilepsy Research Center, Children's Mercy Hospital, Kansas City, Missouri 64108, USA. jmurphy@cmh.edu
Abstract:
Vagal nerve stimulation (VNS) for the treatment of refractory epilepsy appears to have started from the theory that since VNS can alter the EEG, it may influence epilepsy. It proved effective in several models of epilepsy and was then tried in short-term, open-label and double-blind trials, leading to approval in Canada, Europe and the US. Follow-up observations in these patients demonstrated continued improvement in seizure control for up to 2 years. Close to 50% of treated patients have achieved at least a 50% reduction in seizure frequency. This therapy was also useful as rescue therapy for ongoing seizures in some patients; many patients are more alert. The initial trials were completed in patients >/=12 years of age with refractory partial seizures. Subsequently, similar benefits were shown in patients with tuberous sclerosis complex, Lennox-Gastaut syndrome, hypothalamic hamartomas and primary generalised seizures. Implanting the generator and leads is technically easy, and complications are few. The method of action is largely unknown, although VNS appears to alter metabolic activity in specific brain nuclei. Considering that improvement in mood is frequently found in patients using VNS, it has undergone trials in patients with depression. Other illnesses deserving exploration with this unusual therapy are Alzheimer's disease and autism. Some aspects of VNS have proven disappointing. Although patients have fewer seizures, the number of antiepileptic drugs they take is not significantly reduced. In addition, there is no way to accurately predict the end of life of the generator. Optimal stimulation parameters, if they exist, are unknown. Deep brain stimulation is a new method for controlling medically refractory seizures. It is based on the observation that thalamic stimulation can influence the EEG over a wide area. Several thalamic nuclei have been the object of stimulation in different groups of patients. Intraoperative brain imaging is essential for electrode placement. The procedure is done under local anaesthesia. Experience with this therapy is currently limited, but growing.
Insights
Vagal nerve stimulation (VNS) effectively reduces seizure frequency in epilepsy patients, with nearly 50% experiencing at least a 50% reduction. This therapy shows promise for various epilepsy types and other neurological conditions.
Area of Science:
- Neurology
- Neurosurgery
- Epileptology
Background:
- Vagal nerve stimulation (VNS) emerged from the theory that altering EEG patterns could influence epilepsy.
- Initial trials focused on refractory partial seizures in patients aged 12 and older.
Purpose of the Study:
- To evaluate the efficacy and safety of VNS in treating refractory epilepsy.
- To explore VNS potential in other neurological and psychiatric conditions.
Main Methods:
- VNS implantation with generator and leads.
- Open-label and double-blind trials.
- Follow-up observations up to 2 years.
Main Results:
- Nearly 50% of patients achieved ≥50% seizure frequency reduction.
- Continued seizure control improvement observed up to 2 years.
- Benefits extended to tuberous sclerosis complex, Lennox-Gastaut syndrome, and primary generalized seizures.
Conclusions:
- VNS is a safe and effective adjunctive therapy for refractory epilepsy.
- VNS may hold potential for treating depression, Alzheimer's disease, and autism.
- Further research is needed to optimize VNS parameters and predict generator longevity.